OakChart

BioHarvest Sciences Inc

BHSTConsumer Defensive·Packaged Foods·Canada·Nano·NASD·Nov 11 • 3:59 PM ET

1.75-0.04 (-2.23%)
2026-11-12 00:00 CET
Market cap
31.02 USD m
Revenue, TTM
35.48 USD m
Net income, TTM
-11.07 USD m
Free cash flow, TTM
-16.66 USD m
EPS diluted, TTM
-0.52
P/E
-
Compare

Price

BHST against its 20, 50 and 200-day averages
2050200beatmissearnings
2.004.006.00119K238KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BHSTclose 1.7520-day 1.6850-day 1.65200-day 3.101.7552w low

78.9% under the 52-week high of 8.30 on 13 Nov 2025. 52-week low 1.37 on 7 Oct 2026. Last 15 sessions, 46.4% high to low

Volume 0.32× normal · the line is the 50-bar volume average

Profile

BHST
52-week range, 5% of the way up
1.378.30

BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.

Employees89
IPOMar 08, 2019
Beta1.28
ATR, 14d0.14
Rel volume0.32
Short float0.52%
Insider own16.12%
Inst own9.91%

Snapshot

6 groups

Valuation

Index-
Market Cap39.67M
Enterprise Value41.00M
Income-11.07M
Sales35.48M
Book/sh0.87
Cash/sh0.72
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees89
IPOMar 08, 2019

Ratios

P/E-
Forward P/E-
PEG-
P/S1.12
P/B2.01
P/C2.45
P/FCF-
EV/EBITDA-
EV/Sales1.16
Quick Ratio1.75
Current Ratio2.24
Debt/Eq0.89
LT Debt/Eq0.66
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.52
EPS next Y-0.34
EPS next Q-0.14
EPS this Y12.08%
EPS next Y36.49%
EPS next 5Y-
EPS past 3/5Y11.10% 2.26%
Sales past 3/5Y84.46% 144.37%
EPS Y/Y TTM24.63%
Sales Y/Y TTM17.50%
EPS Q/Q30.37%
Sales Q/Q3.78%
EarningsNov 12 BMO
EPS/Sales Surpr.-44.68% -6.50%

Ownership

Insider Own16.12%
Insider Trans0.00%
Inst Own9.91%
Inst Trans-0.75%
ROA-30.60%
ROE-142.50%
ROIC-33.66%
Gross Margin58.95%
Oper. Margin-17.99%
Profit Margin-31.21%
SMA204.47%
SMA506.12%
SMA200-43.53%
Trades-

Technical

Shs Outstand22.67M
Shs Float14.53M
Short Float0.52%
Short Ratio2.31
Short Interest0.08M
52W High8.30 -78.92%
52W Low1.37 27.64%
Volatility13.08% 10.05%
ATR (14)0.14
RSI (14)55.59
Beta1.28
Rel Volume0.32
Avg Volume32.74K
Volume10,344

Performance

Perf Week19.86%
Perf Month-3.85%
Perf Quarter-15.46%
Perf Half Y-56.30%
Perf YTD-66.28%
Perf Year-74.56%
Perf 3Y-57.45%
Perf 5Y-83.75%
Perf 10Y-
Recom1.00
Target Price10.50
Prev Close1.79
Price1.75
Change %-2.23%

Analyst ratings

latest 3 of 3
DateActionAnalystRating changeTargetImplied
Feb 19, 2026InitiatedRRoth CapitalBuy$10+471.4%
May 05, 2025InitiatedCCraig HallumBuy$15+757.1%
Dec 18, 2024InitiatedMMaxim GroupBuy$12+585.7%

Peers

Mkt cap
TickerCompanyMkt cap
LFVNLifevantage Corp59.86M
FTLFFitLife Brands Inc78.13M
NAIINatural Alternatives International Inc6.46M
NATRNature's Sunshine Products Inc178.66M
LSFLaird Superfood Inc27.98M
PREPrenetics Global Limited298.78M
USNAUsana Health Sciences Inc237.42M
HLFHerbalife Ltd1.63B
SMPLSimply Good Foods Co1.10B
BRBRBellring Brands Inc1.16B

News

latest 14 of 198

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--0.138--9.314
2026Q22026-08-11-0.170-0.118-0.1658.849.454
2026Q12026-05-14-0.110-0.120-0.1178.518.504
2025Q42026-03-31-0.100-0.105-0.1009.109.244
2025Q32025-11-13-0.140-0.115-0.1449.079.114
2025Q22025-08-11-0.240-0.110-0.2358.528.533
2025Q12025-05-15-0.130-0.120-0.1357.867.814
2024Q42025-03-31-0.170-0.123-0.1717.307.243
2024Q32024-11-25-0.160--0.1556.54--
2024Q22024-08-29-0.040-0.100-0.0426.035.971
2026Q4---0.115--10.774
2027Q1---0.123--10.213
2027Q2---0.110--10.983
2027Q3---0.063--12.653
2027Q4---0.020--14.683
2028Q1---0.070--14.121

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY-0.800-0.780-0.79725.1925.15
2025FY-0.600-0.618-0.60034.5134.68
2026FY--0.528--37.42
2027FY--0.335--49.59
2028FY-0.130--71.53
2029FY-0.440--107.55
2030FY-0.990--142.9

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-254009.318.8510.41
2026Q3S2026-08-114049.318.8510.41
2026Q3S2026-07-2840011.4010.5512.18
2026Q3S2026-06-1640311.4010.5512.18
2026Q3S2026-05-1440411.4010.5512.18
2026Q3S2026-04-2242212.0911.3912.47
2026Q3S2026-04-1341212.0311.3912.47
2026Q3S2026-04-0231212.0111.3912.47
2026Q3S2026-04-0131112.3711.3913.27
2026Q3S2026-02-1830012.4411.5613.27
2026Q3S2026-01-2820012.0211.5612.48
2026Q3S2026-01-1220112.0211.5612.48
2026Q3S2025-11-1420212.0211.5612.48
2026Q3S2025-11-1130114.3712.0918.52

Estimate history

EPS, annual-1.75-0.09-15.846-0.678-0.79-0.861-0.929-0.797-0.605-0.5246
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.042-0.155-0.171-0.135-0.235-0.144-0.1-0.117-0.164
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual000.2180.3962.1025.49812.67225.18834.50835.48
Period201720182019202020212022202320242025TTM
Sales, quarterly6.0276.5397.2787.868.5159.0679.0668.5078.837
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.00396.5770.26911.73212.96112.96113.67717.32822.66722.668
Period201720182019202020212022202320242025MRQ
Shares, quarterly17.32817.32817.32817.32817.33319.61622.66722.66822.668
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue35.4834.5125.1912.675.502.100.400.220.00
Cost of Goods Sold Incl. D&A14.5614.8911.987.454.991.770.540.490.00
Gross Profit20.9119.6213.215.220.510.33-0.14-0.270.00
Selling, General and Administrative Excl. Other27.3025.1920.2015.1811.128.825.431.971.62
Research and Development5.794.904.463.112.314.061.111.051.10
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-6.38-5.58-6.99-9.97-10.61-8.49-5.57-2.24-1.62
Interest Expense4.863.711.931.070.590.850.512.250.00
Unusual Expense0.000.003.501.030.260.770.560.082.73
Net Income Before Taxes-10.98-11.06-12.91-12.56-11.24-9.83-6.58-5.31-5.14
Income Taxes0.100.080.010.000.000.000.000.000.00
Consolidated Net Income-11.07-11.14-12.91-12.56-11.24-9.83-6.58-5.31-5.14
Net Income From Continuing Operations-11.07-11.14-12.91-12.56-11.24-9.83-6.58-4.27-5.14
Net Income-11.07-11.14-12.91-12.56-11.24-9.83-6.58-4.27-5.14
EPS (Recurring)-0.49-0.60-0.65-0.88-0.85-0.75-0.64-15.64-0.06
EPS (Basic, Before Extraordinaries)-0.52-0.60-0.80-0.93-0.86-0.79-0.68-15.85-0.09
EPS (Diluted)-0.52-0.60-0.80-0.93-0.86-0.79-0.68-15.85-0.09
EBITDA-4.64-3.95-5.74-9.12-9.90-8.10-5.28-1.92-1.62
Non-Operating Income (Expense)0.27-1.78-0.48-0.500.230.290.06-0.74-0.78
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.700.440.430.561.353.371.250.460.43
Price To Sales Ratio1.832.773.975.9218.1474.62154.534.33-
Gross Margin58.9556.8552.4441.189.2215.70-35.35-124.77-
Operating Margin-17.99-16.16-27.75-78.65-193.02-403.95-1,405.81-1,027.52-
Net Margin-31.21-32.27-51.27-99.15-204.37-467.51-1,662.63-1,958.72-
Shares Outstanding22.6722.6717.3313.6812.9612.9611.730.2796.58
Market Capitalization31.0231.02107.0975.75100.57163.3173.91361.3515.45

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue8.848.519.079.078.527.867.286.54
Cost of Goods Sold Incl. D&A3.763.473.843.503.433.273.162.83
Gross Profit5.085.045.225.575.094.594.123.71
Selling, General and Administrative Excl. Other7.596.876.356.496.906.315.815.82
Research and Development1.661.391.301.431.341.251.401.28
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.51-1.83-1.12-0.92-1.81-1.72-1.69-2.10
Interest Expense1.250.881.201.532.230.581.260.59
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-3.66-2.60-2.27-2.45-4.04-2.30-2.95-2.69
Income Taxes0.050.05-0.060.060.040.040.010.00
Consolidated Net Income-3.72-2.64-2.20-2.51-4.08-2.34-2.96-2.69
Net Income From Continuing Operations-3.72-2.64-2.20-2.51-4.08-2.34-2.96-2.69
Net Income-3.72-2.64-2.20-2.51-4.08-2.34-2.96-2.69
EPS (Recurring)-0.16-0.12-0.10-0.14-0.24-0.13-0.17-0.16
EPS (Basic, Before Extraordinaries)-0.16-0.12-0.10-0.14-0.24-0.13-0.17-0.16
EPS (Diluted)-0.16-0.12-0.10-0.14-0.24-0.13-0.17-0.16
EBITDA-2.02-1.41-0.69-0.54-1.41-1.32-1.35-1.75
Non-Operating Income (Expense)0.100.110.050.000.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.340.160.110.100.140.100.110.13
Price To Sales Ratio1.832.803.315.013.863.874.254.35
Gross Margin57.5159.2157.6361.4359.7358.4656.6556.80
Operating Margin-28.37-21.56-12.36-10.15-21.32-21.87-23.18-32.15
Net Margin-42.04-31.05-24.31-27.72-47.92-29.75-40.62-41.12
Shares Outstanding22.6722.6722.6719.6217.3317.3317.3317.33
Market Capitalization31.0275.2089.93163.05116.62107.26107.0977.00

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments23.022.395.361.744.121.780.910.530.00
Short Term Receivables2.311.361.231.210.620.350.280.000.00
Inventories4.563.652.471.380.930.100.050.000.00
Other Current Assets0.600.45-----0.340.00
Total Current Assets30.507.869.054.325.672.241.240.870.00
Net Property, Plant & Equipment16.7316.775.774.914.362.920.650.000.00
Total Investments and Advances0.430.370.180.160.180.140.130.000.00
Intangible Assets0.000.000.000.000.000.000.004.760.00
Other Assets0.000.000.000.000.000.000.000.000.00
Total Assets47.6625.0015.009.3910.215.302.025.620.00
Short Term Debt Incl. Current Port. of LT Debt2.117.1021.460.340.390.3223.700.000.00
Accounts Payable2.633.521.781.070.880.430.400.000.00
Other Current Liabilities2.953.633.2310.111.661.142.360.030.00
Total Current Liabilities7.6814.2626.4711.522.921.8926.470.030.00
Long Term Debt14.539.413.393.684.095.712.520.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.120.340.000.011.880.00
Total Liabilities22.2223.6729.8615.327.357.6028.991.910.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.010.000.00
Common Equity25.451.33-14.85-5.932.85-2.29-30.553.72-0.00
Total Shareholders Equity25.451.33-14.85-5.932.85-2.29-30.533.72-0.00
Accumulated Minority Interest0.000.000.000.000.000.003.560.000.00
Total Equity25.451.33-14.85-5.932.85-2.29-26.973.72-0.00
Total Liabilities & Stockholders Equity47.6625.0015.009.3910.215.302.025.620.00
Book Value Per Share1.120.08-1.09-0.460.22-0.20-113.360.04-1.40
Tangible Book Value Per Share1.120.08-1.09-0.460.22-0.20-113.36-0.01-1.40
Full-Time Employees8987-------
Price to Book Ratio2.0525.87-9.77-28.3957.20-32.2194.063.103.29
Return on Assets-30.65-64.56-103.00-114.65-126.70-179.74--170.77-11.93
Return on Equity-83.17----3,509.64---252.32-121.00
Return on Invested Capital-27.85-120.20---141.50-193.08--138.15-
Quick Ratio3.380.290.250.261.621.130.0532.150.00
Current Ratio3.970.550.340.381.941.180.0532.150.00

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-10.95-11.14-12.91-12.56-11.24-9.83-6.58-5.31-5.14
Depreciation1.721.621.250.840.710.390.290.32-
Other Funds (Non Cash)-1.80-1.554.842.451.592.742.651.933.90
Funds from Operations-11.03-11.06-6.82-9.28-8.93-6.70-3.64-3.06-1.24
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-3.41-1.94-0.560.76-0.31-0.10-0.230.67-0.45
Cash from Operating Activities-14.44-13.00-7.38-8.52-9.24-6.79-3.88-2.38-1.69
Capital Expenditures-2.22-2.36-2.84-1.47-1.26-1.64-0.17-0.030.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.00-0.000.002.23
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-1.01-0.01-0.190.000.000.000.000.000.00
Other Sources-0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-3.23-2.37-3.03-1.47-1.26-1.64-0.17-0.032.23
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock25.1525.104.740.400.8811.104.470.740.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock25.1525.104.740.400.8811.104.470.740.00
Proceedsfrom Stock Options25.1125.064.330.000.007.474.470.740.00
Issuance or Reduction of Debt, Net6.1812.243.3113.527.660.000.711.630.00
Change in Long Term Debt6.1812.243.3113.527.660.000.77-0.070.00
Issuance of Long Term Debt6.3412.403.3113.527.660.000.770.000.00
Reduction of Long Term Debt-0.16-0.160.000.000.000.000.00-0.070.00
Net Financing Active Other Cash Flow-0.260.000.000.00-0.040.000.000.000.00
Other Financing Activities Uses-0.260.000.000.00-0.040.000.000.000.00
Cash from Financing Activities29.1235.967.4713.568.1410.774.932.120.00
Exchange Rate Effect0.090.04-0.030.06-0.02-0.00-0.010.01-0.01
Net Change in Cash11.5420.64-2.973.62-2.382.330.87-0.290.53
Free Cash Flow-16.66-15.35-10.21-10.00-10.50-8.43-4.05-2.42-1.69
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00-0.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments16.2219.1723.0210.973.733.40
Short Term Receivables4.183.182.312.442.472.23
Inventories5.784.974.564.434.134.01
Other Current Assets-1.000.60---
Total Current Assets26.1828.3230.5017.8410.339.64
Net Property, Plant & Equipment17.9316.8016.7316.9417.0716.59
Total Investments and Advances0.460.440.430.410.400.36
Intangible Assets0.000.000.000.000.000.00
Other Assets0.000.000.000.000.000.00
Total Assets44.5745.5647.6635.1927.8026.59
Short Term Debt Incl. Current Port. of LT Debt4.423.462.115.587.7310.04
Accounts Payable2.752.682.633.483.423.73
Other Current Liabilities4.513.442.954.125.965.16
Total Current Liabilities11.689.587.6813.1917.1118.93
Long Term Debt13.1312.9614.5314.2614.928.53
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities24.8022.5422.2227.4532.0227.47
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity19.7623.0225.457.74-4.22-0.88
Total Shareholders Equity19.7623.0225.457.74-4.22-0.88
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity19.7623.0225.457.74-4.22-0.88
Total Liabilities & Stockholders Equity44.5745.5647.6635.1927.8026.59
Book Value Per Share0.871.021.120.39-0.24-0.05
Tangible Book Value Per Share0.871.021.120.39-0.24-0.05
Full-Time Employees--89---
Price to Book Ratio2.053.8713.16-38.62-133.1480.64
Return on Assets-30.60-31.71-30.65-38.97-44.02-43.89
Return on Equity-142.50-103.29-83.17-200.22-973.22-
Return on Invested Capital-11.29-7.34-5.51-11.42-38.16-30.53
Quick Ratio1.752.443.381.020.360.30
Current Ratio2.242.963.971.350.600.51

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-3.69-2.64-2.09-2.54-4.19-2.34
Depreciation0.490.430.420.390.420.40
Other Funds (Non Cash)1.540.63-4.780.811.920.50
Funds from Operations-1.65-1.59-6.45-1.34-1.86-1.44
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.120.01-1.53-0.780.350.01
Cash from Operating Activities-2.77-1.58-7.97-2.12-1.51-1.43
Capital Expenditures-0.56-0.59-0.63-0.43-0.61-0.68
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.00-1.00-0.010.000.000.00
Other Sources0.000.00-0.00-0.000.000.00
Cash from Investing Activities-0.56-1.59-0.65-0.43-0.61-0.68
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.0019.225.930.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.0019.225.930.000.00
Proceedsfrom Stock Options0.000.0025.110.000.000.00
Issuance or Reduction of Debt, Net0.11-0.111.804.372.753.34
Change in Long Term Debt0.11-0.111.804.372.753.34
Issuance of Long Term Debt0.000.001.964.372.753.34
Reduction of Long Term Debt0.11-0.11-0.160.000.000.00
Net Financing Active Other Cash Flow-0.23-0.030.000.000.000.00
Other Financing Activities Uses-0.23-0.030.000.000.000.00
Cash from Financing Activities-0.67-0.6420.569.872.483.12
Exchange Rate Effect0.08-0.050.040.02-0.01-0.00
Net Change in Cash-3.92-3.8611.977.350.351.01
Free Cash Flow-3.33-2.17-8.61-2.55-2.12-2.11

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.52%0.1M14.5M38.92K
2026-10-150.62%0.1M14.5M49.26K
2026-09-300.68%0.1M14.5M52.80K
2026-09-150.66%0.1M14.5M52.33K
2026-08-310.51%0.1M14.5M49.39K
2026-08-140.50%0.1M14.5M47.18K
2026-07-310.50%0.1M14.5M40.47K
2026-07-150.50%0.1M14.5M30.61K
2026-06-300.50%0.1M14.5M30.95K
2026-06-150.46%0.1M14.5M29.22K
2026-05-290.49%0.1M14.5M28.53K
2026-05-150.46%0.1M14.5M27.65K
2026-04-300.45%0.1M14.5M23.44K
2026-04-150.45%0.1M14.5M26.23K
2026-03-310.43%0.1M14.9M26.54K
2026-03-130.42%0.1M14.9M33.98K
2026-02-270.46%0.1M14.9M41.10K
2026-02-130.42%0.1M14.9M50.75K
2026-01-300.41%0.1M14.9M70.81K
2026-01-150.41%0.1M14.9M74.65K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-29SEC
2026-10-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-13SEC
2026-10-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-08SEC
2026-10-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-01SEC
2026-09-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-15SEC
2026-09-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-15SEC
2026-09-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-14SEC
2026-09-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-03SEC
2026-08-126-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-11SEC
2026-08-116-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-11SEC
2026-07-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-29SEC
2026-07-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-28SEC
2026-07-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-15SEC
2026-07-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-15SEC
2026-06-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-18SEC
2026-05-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-27SEC
2026-05-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-14SEC
2026-05-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC
2026-05-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-12SEC
2026-05-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-13SEC
2026-05-126-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-12SEC
2026-05-116-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-11SEC
2026-05-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-30SEC
2026-04-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-29SEC
2026-03-3140-FRegistration Statement Pursuant to Section 12 of the Securities Exchange Act of 1934 or Annual Report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 19342025-12-31SEC
2026-03-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-26SEC
2026-03-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-17SEC
2026-03-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-13SEC
2026-03-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-06SEC
2026-03-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-05SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Alyeska Investment Group, L.P.3.36%
THOMPSON SIEGEL & WALMSLEY LLC2.10%
Evercore Wealth Management, LLC1.25%
True North Advisors, LLC1.08%
Magnus Financial Group LLC0.52%
Silverberg Bernstein Capital Management LLC0.48%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.37%
TD Waterhouse Canada Inc.0.25%
KING LUTHER CAPITAL MANAGEMENT CORP0.23%
CITADEL ADVISORS LLC0.12%

Funds

Fund% owned
Fidelity Nasdaq Composite Index Fund0.02%

OakChart. BHST. Cached 15 minutes.

Some panels did not load: insider.